Session

26.03.2021     13:30–14:15

Title:
Poster session 3
Vaccines
Type:
ePoster session

26.03.2021
13:30–14:15

Title:
Poster session 3
Vaccines
Type:
ePoster session


13:30–13:35
PS 117 Influence of HCMV variants expressing NKG2D ligands on immune cell activation
Greta Meyer (Hannover/DE)
Talk time: 3 + 2 min


13:35–13:40
PS 118 Lasting humoral immune protection upon single-shot vaccination with MCMV based vaccine vectors
Yeonsu Kim (Braunschweig/DE)
Talk time: 3 + 2 min


13:40–13:45
PS 119 Bioconjugation of stabilized HIV envelope trimers to different nanoparticle carriers
David Peterhoff (Regensburg/DE)
Talk time: 3 + 2 min


13:45–13:50
PS 120 Systemic prime followed by a mucosal boost immunization prevent RSV vaccine enhanced respiratory disease
Jana Fuchs (Erlangen/DE)
Talk time: 3 + 2 min


13:50–13:55
PS 121 A highly immunogenic and effective Measles Virus-based Th1-biased COVID-19 vaccine
Cindy Hörner (Langen/DE)
Talk time: 3 + 2 min


13:55–14:00
PS 122 Generation and preclinical development of the COVID-19 candidate vaccine MVA-SARS-2-S 
Alina Tscherne (München/DE)
Talk time: 3 + 2 min


14:00–14:05
PS 123 A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
Kai Dallmeier (Leuven/BE)
Talk time: 3 + 2 min


14:05–14:10
PS 124 Tick-borne encephalitis virus: development of a vaccine approach based on modified vaccinia virus Ankara
Mareike Kubinski (Hannover/DE)
Talk time: 3 + 2 min


14:10–14:15
PS 125 An influenza A virus–based vaccine candidate expressing Zika virus envelope protein domain III
Lucas Wilken (Hannover/DE)
Talk time: 3 + 2 min